Excalipoint Therapeutics
PrivateLast Round
Seed
Mar 18, 2026
Total Funding Raised
$109.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Excalipoint Therapeutics is a biotechnology company developing next-generation T-cell engager (TCE) therapies for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Excalipoint Therapeutics Comparables
Compare Excalipoint Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kali Therapeutics | 84% | |
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 73% | |
| Merck | 73% | |
Excalipoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 18, 2026 | ||||
| Seed | Aug 1, 2025 |
Excalipoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centurium Capital | Seed |
| Co-Win Ventures | Seed |
| YuanBio Venture Capital | Seed |
| Eisai Innovation | Seed |
| Hony Capital | Seed |
| 5Y Capital | Seed |
| MPC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
$69M round led by Centurium Capital and HongShan.
Excalipoint Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Excalipoint Therapeutics's valuation, stock price, and market status.